Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7

  • Albert R. La Spada
  • , Ying Hui Fu
  • , Bryce L. Sopher
  • , Randell T. Libby
  • , Xuejiao Wang
  • , Lili Y. Li
  • , David D. Einum
  • , Jing Huang
  • , Daniel E. Possin
  • , Annette C. Smith
  • , Refugio A. Martinez
  • , Kari L. Koszdin
  • , Piper M. Treuting
  • , Carol B. Ware
  • , James B. Hurley
  • , Louis J. Ptáček
  • , Shiming Chen

Research output: Contribution to journalArticlepeer-review

230 Scopus citations

Abstract

Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant disorder caused by a CAG repeat expansion. To determine the mechanism of neurotoxicity, we produced transgenic mice and observed a cone-rod dystrophy. Nuclear inclusions were present, suggesting that the disease pathway involves the nucleus. When yeast two-hybrid assays indicated that cone-rod homeobox protein (CRX) interacts with ataxin-7, we performed further studies to assess this interaction. We found that ataxin-7 and CRX colocalize and coimmunoprecipitate. We observed that polyglutamine-expanded ataxin-7 can dramatically suppress CRX transactivation. In SCA7 transgenic mice, electrophoretic mobility shift assays indicated reduced CRX binding activity, while RT-PCR analysis detected reductions in CRX-regulated genes. Our results suggest that CRX transcription interference accounts for the retinal degeneration in SCA7 and thus may provide an explanation for how cell-type specificity is achieved in this polyglutamine repeat disease.

Original languageEnglish
Pages (from-to)913-927
Number of pages15
JournalNeuron
Volume31
Issue number6
DOIs
StatePublished - Sep 27 2001

Fingerprint

Dive into the research topics of 'Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7'. Together they form a unique fingerprint.

Cite this